The share buy-back program will start on March 26, 2025, and is expected to end no later than July 10, 2025 (unless Genmab terminates or suspends the program).

General Hospital fans question Ava's intentions after Sonny collapses on the floor. She went to see Sonny and asked for $2 ...

Genmab A/S, a biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark. Genmab A/S has moved -37.4% over the last year ...

Danish biotech prepares defence against allegations of trade secret misappropriation | AbbVie claims two former employees ...